Antivirals Flashcards
Composition of viruses
Nucleic acid (DNA or RNA) Protein (structural coat, non-structural enzymes) \+/- Lipid envelope
Acute virus infections
RNA viruses
Influenza, measles, mumps, Hep A
Chronic virus infections
Usually DNA viruses
Can be latent with or without recurrences e.g. Herpes simplex, Cytomegalovirus
Can be persistent such as HIV, HTLV, Hep B, Hep C
Non-vesicular viral rashes
Measles Rubella Parvovirus Adenovirus HHV6
Vesicular viral rashes
Chickenpox (HHV3)
Herpes simplex (HHV1/2)
Enterovirus
Respiratory viral infections
Influenza A/B Respiratory Syncytial Virus Parainfluenza virus Human metapnuemovirus Rhinovirus (cold) Coronavirus (including SARS)
Viral infections causing gastroenteritis
Rotavirus Norovirus Astrovirus Sapovirus Adenovirus (group F)
Neurological viral disease
Encephalitis/meningitis! HSV Enteroviruses Rabies Japanese encephalitis virus Nipah virus
Blood-borne viruses
Hepatitis viruses (HBV, HCV Retroviruses (HIV 1, 2 and HTLV 1, 2)
When to use antivirals
Acute infections in general population where high risk of complications
Chronic infections e.g. HIV, HBV, HCV
Infections in the immunocompromised - post-transplant, immunosuppressed patients, those with primary immunodeficiencies
Treatment of chickenpox and shingles
Treat with acicovir Treat all adults with chickenpox Treat shingles if: - The patient is >60 - The eye is involved - They are immunocompromised
Treatment of influenza
Neuraminidase inhibitors (oral oseltamivir and inhaled zanamavir)
Treat high risk patients:
- Chronic neurological, hepatic, renal, pulmonary and chronic cardiac disease
- Diabetes mellitus
- Severe immunosuppression
- Age over 65 years
- Pregnancy (including up to two weeks postpartum)
- Children under 6 months
- Morbid obesity (BMI over 40)
Treatment of chronic virus infections
Usually lifelong antivirals
Antiviral toxicity and maintenance of good adherence can be issues
Need to avoid emergence of resistance
Exception is HCV which is caused by an RNA virus
Virus replication
1: Virus attachment to cell via receptor
2: Cell entry
3: Virus uncoating
4: Early proteins produced - viral enzymes
5: Replication
6: Late transcription/translation - viral structural proteins
7: Virus assembly
8: Virus release and maturation
HAART
Highly Active Antiretroviral Therapy
2 NRTIs + NNRTI or R NRTIs + boosted PI or integrase inhibitor
Often used in fixed drug combinations (more than one drug in pill)
Aim to switch off virus replication
Require life-long treatment